UPDATE: Cantor Fitzgerald Starts Annexon Biosciences (ANNX) at Overweight
Tweet Send to a Friend
(Updated - September 23, 2021 6:31 AM EDT)
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Annexon Biosciences (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Annexon Biosciences (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
